Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
Introduction: influenza is an acute viral disease caused by infection of the upper respiratory tract - difficult to control, which affects a large part of the population. Neuraminidase inhibitors (NAIs), such as oseltamivir and zanamivir, are the antiviral drugs utilized in Romania for the treatment...
Huvudupphovsmän: | Mihai Maria Elena, Ivanciuc Alina Elena, Cherciu Carmen Maria, Mihăescu Grigore, Lazăr Mihaela |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Sciendo
2024-04-01
|
Serie: | Romanian Journal of Laboratory Medicine |
Ämnen: | |
Länkar: | https://doi.org/10.2478/rrlm-2024-0010 |
Liknande verk
-
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
av: Chiara Medaglia, et al.
Publicerad: (2021-06-01) -
Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
av: Zhichao Xu, et al.
Publicerad: (2022-06-01) -
Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
av: Mira C. Patel, et al.
Publicerad: (2024-07-01) -
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
av: Hwajung Yi, et al.
Publicerad: (2010-12-01) -
Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
av: Amytis Gholami, et al.
Publicerad: (2022-08-01)